Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

View All

Latest Posts

About This Stock More About This Stock
Leaders Reporting Tomorrow
Article By: Bespoke Investment Group
Tuesday, February 5, 2019 5:35 PM EST
Among the companies set to report earnings on Wednesday are Regeneron Pharmaceuticals, Chipotle, and Spire.
In this article: REGN, CMG, SR
Read
13 Monster Stock Market Predictions For The Week Of January 28
Article By: Michael J. Kramer
Sunday, January 27, 2019 12:46 PM EST
The week of January 28 will definitely not be a dull one with a monster week for earnings from tech titans and more.
In this article: NKE, ACAD, REGN, GILD, MU, NFLX, GOOGL, SQ, ROKU, BB, BABA, JD
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research
Wednesday, January 23, 2019 2:06 PM EST
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly
Saturday, August 11, 2018 9:37 PM EST
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $REGN

No tweets yet!

$REGN

Comments Status Updates
Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner • 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments